WHO ICTRP trial
Renal Denervation in Heart Failure
ACTRN12615000203550 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12615000203550 |
|---|---|
| Public title | Renal Denervation in Heart Failure |
| Scientific title | A phase II randomised, controlled pilot study to evaluate the safety and feasibility of renal denervation in heart failure patients on maximal medical treatment |
| Primary sponsor | Dr Suku Thambar |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Australia |
| Conditions | Heart Failure; Heart Failure;Cardiovascular - Other cardiovascular diseases |
| Interventions | Catheter-based renal denervation which is a medical procedure using a device. In this study, a multi-electrode catheter-based renal denervation system known as the EnligHTN System, is used. The renal denervation catheter delivers… |
| Registration date | Mar 3, 2015 |
| Target size | 20 |
| Secondary IDs | Nil |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: